Advisory Board June 14, 2023

Amid ongoing shortages of common cancer drugs, many doctors are reporting difficulties maintaining treatments for existing patients — a situation that some health experts are calling a “public health emergency.”

Shortages of cancer drugs are putting patients at risk

Several cancer treatments have been in short supply since March, and these shortages have only worsened over the last few months, leading more patients to face delays in care.

According to a recent survey of 27 major cancer centers from the National Comprehensive Cancer Network (NCCN), 93% reported a shortage of carboplatin, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Physician, Provider, Public Health / COVID, Supply Chain, Technology
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
Why 2025 Could Be A Good Reimbursement Year For CVS And Walgreens
PBM reform dropped in Congress' funding package
2025 and Beyond: Key Trends to Watch in Pharmacy

Share This Article